Search

Your search keyword '"Bregni, Marco"' showing total 452 results

Search Constraints

Start Over You searched for: Author "Bregni, Marco" Remove constraint Author: "Bregni, Marco"
452 results on '"Bregni, Marco"'

Search Results

2. On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study

8. Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

9. Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

10. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

13. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012

15. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

16. Supplementary Data 3 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

17. Supplementary Data 1 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

18. Data from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

19. uncropped western blot gels from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

20. Supplementary Data 4 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

21. Supplementary Data 2 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

22. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

26. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

28. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy

29. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

30. Gene therapy for immunodeficiency due to adenosine deaminase deficiency

31. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib

32. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity

33. Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation

35. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina

36. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

39. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma

41. Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

45. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia

47. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.

Catalog

Books, media, physical & digital resources